Connecticut Innovations reports that the Connecticut Bioscience Innovation Fund (CBIF) has awarded nearly $2 million dollars of funding intended to speed commercializable bioscience breakthroughs toward the market.

“The projects that will receive funding demonstrated the potential to develop technologies that could be commercialized and could greatly enhance their respective industries,” said Jeremy Crisp, executive vice president and chief innovation officer at Connecticut Innovations.